Overview of the CDC Cervical Cancer (Cx3) Study: an educational intervention of HPV testing for cervical cancer screening

VB Benard, M Saraiya, A Greek… - Journal of Women's …, 2014 - liebertpub.com
Background: The recommended screening interval when using the Papanicolaou (Pap) and
human papillomavirus (HPV) test (co-testing) is 5 years. However because providers are …
被引用次数：24 相关文章

Overview of the CDC Cervical Cancer (Cx3) Study: an educational intervention of HPV testing for cervical cancer screening.

VB Benard, M Saraiya, A Greek, NA Hawkins… - 2014 - cabidigitallibrary.org
Background: The recommended screening interval when using the Papanicolaou (Pap) and
human papillomavirus (HPV) test (co-testing) is 5 years. However because providers are …

Overview of the CDC Cervical Cancer (Cx3) Study: An Educational Intervention of HPV Testing for Cervical Cancer Screening

VB Benard, M Saraiya, A Greek… - Journal of women's …, 2014 - stacks.cdc.gov
Background The recommended screening interval when using the Papanicolaou (Pap) and
human papillomavirus (HPV) test (co-testing) is 5 years. However because providers are …

Overview of the CDC Cervical Cancer (Cx3) Study: an educational intervention of HPV testing for cervical cancer screening.

VB Benard, M Saraiya, A Greek… - Journal of Women's …, 2013 - europepmc.org
Background The recommended screening interval when using the Papanicolaou (Pap) and
human papillomavirus (HPV) test (co-testing) is 5 years. However because providers are …
[HTML] nih.gov

[HTML][HTML] Overview of the CDC Cervical Cancer (Cx3) Study: An Educational Intervention of HPV Testing for Cervical Cancer Screening

VB Benard, M Saraiya, A Greek… - Journal of women's …, 2014 - ncbi.nlm.nih.gov
Background The recommended screening interval when using the Papanicolaou (Pap) and
human papillomavirus (HPV) test (co-testing) is 5 years. However because providers are …

Overview of the CDC Cervical Cancer (Cx3) Study: an educational intervention of HPV testing for cervical cancer screening

VB Benard, M Saraiya, A Greek, NA Hawkins… - 2014 - pubmed.ncbi.nlm.nih.gov
Background The recommended screening interval when using the Papanicolaou (Pap) and
human papillomavirus (HPV) test (co-testing) is 5 years. However because providers are …

Overview of the CDC Cervical Cancer (Cx3) Study: An Educational Intervention of HPV Testing for Cervical Cancer Screening.

VB Benard, M Saraiya, A Greek… - Journal of Women's …, 2014 - search.ebscohost.com
Background: The recommended screening interval when using the Papanicolaou (Pap) and
human papillomavirus (HPV) test (co-testing) is 5 years. However because providers are …

[引用][C] Overview of the CDC Cervical Cancer (Cx3) Study: An Educational Intervention of HPV Testing for Cervical Cancer Screening

VB BENARD, M SARAIYA, A GREEK… - Journal of women's …, 2014 - pascal-francis.inist.fr
Overview of the CDC Cervical Cancer (Cx3) Study: An Educational Intervention of HPV
Testing for Cervical Cancer Screening CNRS Inist Pascal-Francis CNRS Pascal and …

Overview of the CDC Cervical Cancer (Cx3) Study: an educational intervention of HPV testing for cervical cancer screening.

VB Benard, M Saraiya, A Greek… - Journal of Women's …, 2013 - europepmc.org
Background The recommended screening interval when using the Papanicolaou (Pap) and
human papillomavirus (HPV) test (co-testing) is 5 years. However because providers are …

Overview of the CDC Cervical Cancer (Cx3) Study: An Educational Intervention of HPV Testing for Cervical Cancer Screening.

VB Benard, M Saraiya, A Greek… - Journal of Women's …, 2014 - search.ebscohost.com
Background: The recommended screening interval when using the Papanicolaou (Pap) and
human papillomavirus (HPV) test (co-testing) is 5 years. However because providers are …